Clinical Trial Update: Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor [NA]

View source ↗

Summary

A completed clinical trial comparing Masimo and Nellcor devices for oxygen targeting in premature infants; the update does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxia
• Premature Birth

Snippet

Sponsor: University of Edinburgh | Conditions: Premature, Premature Infant | NA | Status: COMPLETED